Author: media24

New York, NY November 21, 2023 –(PR.com)– T-Medical Group Inc., a leading provider of medical technology solutions, today announced that it has signed a letter of intent to acquire Telaleaf Health Inc., a privately held Canadian company that develops and markets innovative software solutions for the healthcare industry and owns a wholly owned subsidiary Telaleaf Health GmbH, a German telemedicine company, that specializes in the fast-growing European Cannabis market.

Under the terms of the agreement, T-Medical Group will purchase all the outstanding shares of Telaleaf for a purchase price of forty-five million (45,000,000) common shares of T-Medical. The transaction is expected to close within 60 days, subject to customary closing conditions and regulatory approvals.

“The acquisition of Telaleaf is a significant step forward in our strategy to expand our multinational portfolio of healthcare software solutions,” said Dominick Bianco, Director of T-Medical Group. “Telaleaf products are highly complementary to our own, and we believe that the combination of our two companies will create a leading provider of healthcare software solutions that will help our customers improve the quality and efficiency of healthcare delivery.”

Gavin Treanor, CEO of Telaleaf, added, “We are excited to join forces with T-Medical Group Inc., a leading provider of medical technology solutions. We believe that our combined expertise and resources will allow us to accelerate the development and commercialization of our innovative software solutions, and to better serve our customers.”

The acquisition of Telaleaf is T-Medical’s Groups second acquisition in the past 90-days. In October 2023, T-Medical acquired 365Televet.com, a provider of cloud-based Tele Veterinarian software solutions.

About T-Medical Group Inc.
T-Medical Group Inc. is a leading provider of medical technology solutions. The company’s products and services are designed to improve value, access and quality of patient outcomes. T-Medical Group Inc. is headquartered in Holbrook NY.

About Telaleaf Health Inc.
Telaleaf Health Inc. is a privately held Canadian company that develops and markets innovative software solutions for the healthcare industry. The company’s products help healthcare providers to improve the quality and efficiency of healthcare delivery and patient outcomes. Telaleaf Health is headquartered in Ontario, Canada.

Contact Information:
T-medical Group
Dominick Bianco
800-671-8076
Contact via Email
www.t-medicalgroup.com/index.html

Read the full story here: https://www.pr.com/press-release/900365

Press Release Distributed by PR.com

Source: PR.com

New York, NY November 16, 2023 –(PR.com)– The acquisition marks T-Medical’s entry into the German medical cannabis market, which is currently the largest in Europe, worth over $200 million annually. Telaleaf’s telemedicine platform, educational resources, and network of cannabis physicians will also give T-Medical a significant presence in the German market.

Telaleaf Health GmbH, a specialized telemedicine portal owned and operated by Telaleaf, enables patients to conveniently consult with doctors online about medical cannabis treatment. Telaleaf’s user-friendly platform aims to improve the patient experience by providing seamless access to cannabis experts and resources.

“Telaleaf has built an unrivaled telemedicine platform focused specifically on medical cannabis in Germany,” said T-Medical CEO Dominic Bianco . “With this acquisition, we gain a strong footprint in the high-growth German market and the ability to serve patients nationally through Telaleaf’s impressive digital capabilities.”

T-Medical plans to leverage Telaleaf’s platform, doctor network, and educational tools to expand across Europe. The company will hire experienced cannabis doctors and medical professionals in key markets to roll out Telaleaf’s telemedicine services in other countries.

“By joining T-Medical, we can rapidly scale our platform and cannabis treatment services across Europe,” said Telaleaf CEO Gavin Treanor. “Together, we have the resources and expertise to expand access to medical cannabis globally.”

Germany legalized medical cannabis in 2017, leading to rapid growth in patient demand. However, access remains challenging, with less than 200 specialized doctors writing cannabis prescriptions nationally. Telaleaf solves this through online consultations and by providing physicians with training and support for cannabis treatment.

T-Medical is focused on improving medical cannabis access and education. The acquisition of Telaleaf provides an ideal platform to serve patients and doctors as the medical cannabis market expands globally.

Contact Information:
T-medical Group
Dominick Bianco
800-671-8076
Contact via Email
www.t-medicalgroup.com/index.html

Read the full story here: https://www.pr.com/press-release/899933

Press Release Distributed by PR.com

Source: PR.com